Laboratory Corp. of America Holdings
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Laboratory Corp. of America Holdings's revenues will grow 1.8% and EPS will increase 9.9%.
The average estimate for revenue is $1.45 billion. On the bottom line, the average EPS estimate is $1.77.
Last quarter, Laboratory Corp. of America Holdings logged revenue of $1.41 billion. GAAP reported sales were 2.9% higher than the prior-year quarter's $1.37 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $1.54. GAAP EPS of $1.26 for Q4 were 6.0% lower than the prior-year quarter's $1.34 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 38.3%, 190 basis points worse than the prior-year quarter. Operating margin was 20.8%, 190 basis points better than the prior-year quarter. Net margin was 8.6%, 130 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $5.79 billion. The average EPS estimate is $7.13.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 668 members out of 690 rating the stock outperform, and 22 members rating it underperform. Among 209 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 205 give Laboratory Corp. of America Holdings a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Laboratory Corp. of America Holdings is hold, with an average price target of $93.28.
Is Laboratory Corp. of America Holdings the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Laboratory Corp. of America Holdings to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool recommends Laboratory of America. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why LabCorp, comScore, and Atwood Oceanics Slumped Today
These stocks fell in a quiet market. Find out why.
Do Reverse Splits Ever Work?
Some companies seem doomed to failure when they make desperate moves to lift their share prices, but sometimes, reverse splits get the job done.
3 Healthcare Technologies That Are Set to Transform Our Lives Over the Next 10-20 Years
Three Motley Fool analysts discuss game-changing healthcare technologies.